Theresa Ryan

Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study

Howard S. Höchster, Edie Weller, Randy D. Gascoyne et al. · Journal of Clinical Oncology · 2009 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia

Shannon L. Maude, Sibasish Dolai, Cristina Delgado-Martín et al. · Blood · 2015 · 219 citations · Full text

Medicine, Cancer Biology, Oncology +13

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

Sarah K. Tasian, David T. Teachey, Yong Li et al. · Blood · 2016 · 164 citations · Full text

Medicine, Oncology, Pharmacology +13

Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL

Caroline Diorio, Ryan Murray, Mark Naniong et al. · Blood · 2022 · 131 citations · Full text

Life Sciences, Biotechnology, Genetics +17

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia

David T. Teachey, Cecilia Sheen, Junior Hall et al. · Blood · 2008 · 123 citations · Full text

Medicine, Oncology, Pharmacology +12